Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients.

Kurata K, Yakushijin K, Okamura A, Yamamori M, Ichikawa H, Sakai R, Mizutani Y, Kakiuchi S, Miyata Y, Kitao A, Kawamoto S, Matsuoka H, Murayama T, Minami H.

Cancer Chemother Pharmacol. 2018 May;81(5):839-846. doi: 10.1007/s00280-018-3550-7. Epub 2018 Mar 6.

PMID:
29511796
2.

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study.

Burger JA, Keating MJ, Wierda WG, Hartmann E, Hoellenriegel J, Rosin NY, de Weerdt I, Jeyakumar G, Ferrajoli A, Cardenas-Turanzas M, Lerner S, Jorgensen JL, Nogueras-González GM, Zacharian G, Huang X, Kantarjian H, Garg N, Rosenwald A, O'Brien S.

Lancet Oncol. 2014 Sep;15(10):1090-9. doi: 10.1016/S1470-2045(14)70335-3. Epub 2014 Aug 20.

3.

Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancer.

Besse B, Leighl N, Bennouna J, Papadimitrakopoulou VA, Blais N, Traynor AM, Soria JC, Gogov S, Miller N, Jehl V, Johnson BE.

Ann Oncol. 2014 Feb;25(2):409-15. doi: 10.1093/annonc/mdt536. Epub 2013 Dec 23.

PMID:
24368400
4.

Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma.

Hara H, Tahara M, Daiko H, Kato K, Igaki H, Kadowaki S, Tanaka Y, Hamamoto Y, Matsushita H, Nagase M, Hosoya Y.

Cancer Sci. 2013 Nov;104(11):1455-60. doi: 10.1111/cas.12274. Epub 2013 Oct 18.

5.

Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.

Park JR, Scott JR, Stewart CF, London WB, Naranjo A, Santana VM, Shaw PJ, Cohn SL, Matthay KK.

J Clin Oncol. 2011 Nov 20;29(33):4351-7. doi: 10.1200/JCO.2010.34.3293. Epub 2011 Oct 17.

6.

Efficacy and safety of hepatic arterial infusion of fluorouracil with leucovorin as salvage treatment for refractory liver metastases from colorectal cancer.

Lee HJ, Lee YS, Lee KW, Kim SY, Yoon CJ, Shin DY, Lee YG, Choi SY, Kang SG, Kang SB, Kim JH.

Korean J Intern Med. 2011 Mar;26(1):82-8. doi: 10.3904/kjim.2011.26.1.82. Epub 2011 Mar 2.

8.

Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.

Smith RE, Anderson SJ, Brown A, Scholnik AP, Desai AM, Kardinal CG, Lembersky BC, Mamounas EP.

Clin Breast Cancer. 2002 Dec;3(5):333-40.

PMID:
12533263
9.

Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes.

Russell JA, Tran HT, Quinlan D, Chaudhry A, Duggan P, Brown C, Stewart D, Ruether JD, Morris D, Glick S, Gyonyor E, Andersson BS.

Biol Blood Marrow Transplant. 2002;8(9):468-76.

10.

Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.

Long HJ 3rd, Cross WG, Wieand HS, Webb MJ, Mailliard JA, Kugler JW, Tschetter LK, Kardinal CG, Ebbert LP, Rayson S.

Gynecol Oncol. 1995 May;57(2):235-9.

PMID:
7729741
11.

[High-dose leucovorin and 5-fluorouracil in advanced gastric and colorectal cancer. High-Dose Leucovorin and 5-FU Study Group].

Sasaki T, Ota K, Sakata Y, Matsuoka T, Wakui A, Akazawa S, Ogawa M, Mukaiyama T, Yoshino M, Sakai Y, et al.

Gan To Kagaku Ryoho. 1990 Dec;17(12):2361-8. Japanese.

PMID:
2260872
12.

120 hours simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancer.

Fernández Hidalgo O, González F, Gil A, Campbell W, Barrajón E, Lacave AJ.

Am J Clin Oncol. 1989 Oct;12(5):397-401.

PMID:
2801599
13.

[Cis-diamminedichloroplatinum (CDDP)-radiation therapy in nasopharyngeal carcinoma].

Chatani M, Teshima T, Inoue T, Tsuruta Y, Umatani K, Yoshino K, Miyahara H, Sato T.

Gan To Kagaku Ryoho. 1986 May;13(5):1851-6. Japanese.

PMID:
3707147

Supplemental Content

Loading ...
Support Center